From Europe. For the global patent community.
Trending Topics:
JUVE Patent Pharmaceuticals

Pharmaceuticals

Cases
mRNA technology

EPO revokes Moderna patent in vaccine dispute with BioNTech

In the pan-European dispute between Moderna and BioNTech over mRNA patents, the patent holder Moderna has now suffered a defeat at the European Patent ...

21 November 2023 by Konstanze Richter
Cases
The Netherlands

Bayer and Simmons & Simmons repel Sandoz nullity suit over Xarelto

The District Court of The Hague has ruled that Sandoz may not sell its generic version of rivaroxaban in the Netherlands, even after the expiry of an ...

16 November 2023 by Konstanze Richter
Cases
France

No damages for Lilly France in Pemetrexed dispute with Viatris

Eli Lilly has been battling with various generic manufacturers over pemetrexed for years. French courts recently awarded the patent holder millions in ...

7 November 2023 by Konstanze Richter
Cases
Supplementary protection certificates

Formycon and Janssen Biotech put EU SPC waiver to the test in Munich

Despite the 2019 amendment to the EU regulation for SPCs, German pharmaceutical company Formycon may not yet produce a biosimilar of drug Stelara in G ...

26 October 2023 by Konstanze Richter
Sponsored Content Legal Commentary

Patenting Medical Use Inventions in China

Patenting Medical Use Inventions in China A medical use of a product may relate to i) the use of a new drug to treat a disease (“first medical use”);…

23 October 2023 by JUVE
People & Business
Interview

Brigitte Carion-Taravella: “The current situation with SPCs is a mess”

As a European patent attorney at Sanofi, Brigitte Carion-Taravella has decades of experience in patent prosecution and in-house IP rights management. ...

20 October 2023 by Amy Sandys
Legal Commentary
Unified Patent Court

First UPC Court of Appeal decision clarifies deadline for defendants

The judges of the UPC Court of Appeal have issued their first ever ruling and harmonised UPC law. In the infringement dispute between Amgen, Sanofi an ...

18 October 2023 by Mathieu Klos
Cases
The Netherlands

Grünenthal and Freshfields win injunction against Teva testosterone drug

In preliminary injunction proceedings, the District Court of The Hague has ruled in favour of Grünenthal in its claims against Teva over a testosteron ...

9 October 2023 by Amy Sandys
Cases
The Netherlands

Dutch Patent Office and District Court deny SPC for Novartis/Genmab MS drug

The District Court of The Hague has backed the Netherlands Patent Office's rejection of a request by Novartis and Genmab to grant a supplementary prot ...

2 October 2023 by Amy Sandys
Cases
German judiciary

Kühnen grapples with Mylan dura vs. Teva damages claim on final day of hearings

On his last day of hearings before retirement, Thomas Kühnen, presiding judge of the patent senate at Düsseldorf's Higher Regional Court, got to grips ...

25 September 2023 by Konstanze Richter
People & Business
Ireland

Pinsent Masons consolidates Dublin presence with hire from Novartis

Pinsent Masons is continuing to grow its presence across the UK and Ireland with the hire of partner Michael Stewart, who this week joined the firm's ...

13 September 2023 by Amy Sandys
People & Business
UK

Pinsent Masons hires senior patent partner from Taylor Wessing

International firm Pinsent Masons has added yet another partner to its London-based patent team. James Marshall, whose practice focuses on both life s ...

5 September 2023 by Amy Sandys
Cases
The Netherlands

Bristol-Myers Squibb and Hogan Lovells remove generics from Dutch market in apixaban dispute

Sandoz, Stada and Teva are not allowed to sell their generic versions of the blood-clot drug apixaban in the Netherlands after all. This was decided b ...

30 August 2023 by Mathieu Klos
Cases
mRNA vaccines

Düsseldorf Regional Court waits for validity judgments in CureVac v BioNTech

Tuesday marked the start of the high-profile infringement trial between CureVac and BioNTec over mRNA patents. Düsseldorf Regional Court's 4c Civil Ch ...

17 August 2023 by Konstanze Richter
Cases
Breast cancer drug

EPO revokes Novartis everolimus patent in major victory for generics companies

In the long-running dispute with Novartis over breast cancer drug Afinitor, generic drug manufacturers have now scored a major victory. The EPO Boards ...

15 August 2023 by Konstanze Richter
Popular